Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. The Company's lead product, ilixadencel, has been developed to be able to take advantage of each patient's own tumor antigen. Immunicum is also engaged in research and development for production of pharmaceuticals.